The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 28th 2024
Rising health care costs and the complex nature of medication management have prompted PBMs to adopt AI tools to enhance patient outcomes, streamline claims processes, reduce waste, and design smarter, data-driven health plans.
FDA to Review 2 Abuse-Deterrent Opioids
February 16th 2015The FDA recently accepted for review New Drug Applications for Collegium Pharmaceuticals' extended-release oxycodone formulation (Xtampza ER) and Pfizer's extended-release oxycodone hydrochloride and naltrexone hydrochloride (ALO-02), a pair of opioid analgesics with abuse-deterrent properties.
Read More
Narcotics Commonly Dispensed for Children with IBD
February 14th 2015Narcotics are not recommended for managing chronic pain in children with inflammatory bowel disease, due to gastrointestinal side effects and potential dependence. Nevertheless, researchers have uncovered that long-term narcotic use is more than twice as prevalent in pediatric IBD patients compared with the general population.
Read More